Insider Trading History of Murphy James R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Murphy James R since 2006. The trader's CIK number is 1218893. At the time of the last reporting, Murphy James R was the Chairman & CEO of Cpex Pharmaceuticals, Inc.. (stock ticker symbol CPEX). Also see all insider trading activities at Cpex Pharmaceuticals, Inc..

Note that in the past MURPHY JAMES R also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Bentley Pharmaceuticals Inc (BNT) by Murphy James R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 BNT 0 $0 0 $0 11,250 $0
2007 BNT 0 $0 0 $0 6,750 $0
2006 BNT 0 $0 0 $0 200,000 $946,000

Yearly summary of insider trading at Cpex Pharmaceuticals, Inc. (CPEX) by Murphy James R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 CPEX 0 $0 0 $0 73,067 $539,574


Insider trading activities at 2 companies by Murphy James R:

1. Bentley Pharmaceuticals Inc (BNT)

2. Cpex Pharmaceuticals, Inc. (CPEX)

Table 1. Insider trading of Bentley Pharmaceuticals Inc (BNT) by Murphy James R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-05-23 BNT Option Ex 11,250 .00 0
2007-05-23 BNT Option Ex 6,750 .00 0
2006-03-23 BNT Option Ex 200,000 4.73 946,000

Table 2. Insider trading of Cpex Pharmaceuticals, Inc. (CPEX) by Murphy James R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-10-10 CPEX Option Ex 70,367 7.67 539,574
2008-07-22 CPEX Option Ex 2,700 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murphy James R (Chairman & CEO of Cpex Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.